# Abeona Therapeutics Inc.: filings

ABEO · Nasdaq · CIK 318306 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abeo.md) · [Financials](/companies/abeo/financials.md) · [Filings](/companies/abeo/filings.md) · [Insiders](/companies/abeo/insiders.md)

## Reports and events: 331 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 323, 8-K 197, 144 57, 10-Q 53, SC 13G/A 45, CORRESP 29, 3 26, SC 13G 24, DEF 14A 20, 424B5 19, 10-K 18, S-1/A 18, UPLOAD 18, EFFECT 14, S-8 14, SCHEDULE 13G/A 12, SC 13D/A 9, 4/A 7, 8-K/A 7, SCHEDULE 13G 7, POS AM 6, PRE 14A 6, S-3 6, AW 5, S-1 5, CT ORDER 4, D 4, DEFA14A 4, S-3/A 4, 424B3 3, 424B1 2, ARS 2, PRE 14C 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 25-NSE 1, 424B4 1, 8-A12B 1, CERTNAS 1, DEF 14C 1, DEFR14A 1, NT 10-Q 1, NTN 10Q 1, PRER14A 1, PX14A6G 1, RW 1, SC 13D 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 14:38 ET | [SCHEDULE 13D](/filings/0001477932-26-006433.md) | Ownership report, active investor | 0001477932-26-006433 |
| 2026-09-15 | 12:00 ET | [8-K](/filings/0001493152-26-042702.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042702 |
| 2026-08-13 | 07:30 ET | [10-Q](/filings/0001493152-26-037576.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037576 |
| 2026-08-13 | 07:30 ET | [8-K](/filings/0001493152-26-037575.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037575 |
| 2026-06-12 | 16:30 ET | [8-K](/filings/0001493152-26-028458.md) | 5.07 Shareholder vote results | 0001493152-26-028458 |
| 2026-06-12 | 07:30 ET | [8-K](/filings/0001493152-26-028369.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-028369 |
| 2026-06-10 | 16:15 ET | [8-K](/filings/0001493152-26-028106.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028106 |
| 2026-06-04 | 07:30 ET | [8-K](/filings/0001493152-26-027197.md) | 8.01 Other events | 0001493152-26-027197 |
| 2026-05-13 | 07:35 ET | [10-Q](/filings/0001493152-26-022614.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022614 |
| 2026-05-13 | 07:30 ET | [8-K](/filings/0001493152-26-022610.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022610 |
| 2026-04-27 | 16:30 ET | [DEF 14A](/filings/0001493152-26-019153.md) | Proxy statement, period 2026-04-27 | 0001493152-26-019153 |
| 2026-04-07 | 08:35 ET | [8-K](/filings/0001493152-26-015451.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-015451 |
| 2026-03-20 | 16:30 ET | [8-K](/filings/0001493152-26-011863.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-011863 |
| 2026-03-17 | 07:36 ET | [10-K](/filings/0001493152-26-010413.md) | Annual report, period 2025-12-31 | 0001493152-26-010413 |
| 2026-03-17 | 07:30 ET | [8-K](/filings/0001493152-26-010408.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-010408 |
| 2026-03-09 | 07:30 ET | [8-K](/filings/0001493152-26-009299.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009299 |
| 2025-11-12 | 07:35 ET | [10-Q](/filings/0001493152-25-021723.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021723 |
| 2025-11-12 | 07:30 ET | [8-K](/filings/0001493152-25-021721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021721 |
| 2025-08-14 | 07:31 ET | [10-Q](/filings/0001641172-25-023716.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023716 |
| 2025-08-14 | 07:30 ET | [8-K](/filings/0001641172-25-023715.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023715 |
| 2025-07-18 | 16:15 ET | [8-K](/filings/0001641172-25-020227.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-020227 |
| 2025-07-02 | 07:30 ET | [8-K](/filings/0001641172-25-017460.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-017460 |
| 2025-05-19 | 16:15 ET | [8-K](/filings/0001641172-25-011452.md) | 5.07 Shareholder vote results | 0001641172-25-011452 |
| 2025-05-15 | 07:35 ET | [10-Q](/filings/0001641172-25-010516.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010516 |
| 2025-05-15 | 07:30 ET | [8-K](/filings/0001641172-25-010514.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010514 |
| 2025-05-12 | 07:30 ET | [8-K](/filings/0001641172-25-009564.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-009564 |
| 2025-04-29 | 08:00 ET | [8-K](/filings/0001641172-25-006584.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-006584 |
| 2025-04-29 | 06:02 ET | [8-K](/filings/0001641172-25-006548.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006548 |
| 2025-04-09 | 16:15 ET | [DEF 14A](/filings/0001641172-25-003411.md) | Proxy statement, period 2024-12-31 | 0001641172-25-003411 |
| 2025-03-20 | 07:45 ET | [8-K](/filings/0001493152-25-010981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-010981 |
| 2025-03-20 | 07:30 ET | [10-K](/filings/0001493152-25-010978.md) | Annual report, period 2024-12-31 | 0001493152-25-010978 |
| 2024-12-20 | 16:15 ET | [8-K](/filings/0001493152-24-051060.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-051060 |
| 2024-11-14 | 07:30 ET | [10-Q](/filings/0001493152-24-045340.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045340 |
| 2024-11-14 | 07:30 ET | [8-K](/filings/0001493152-24-045338.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045338 |
| 2024-11-12 | 17:24 ET | [DEF 14A](/filings/0001493152-24-044862.md) | Proxy statement, period 2024-11-12 | 0001493152-24-044862 |
| 2024-11-12 | 07:30 ET | [8-K](/filings/0001493152-24-044514.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044514 |
| 2024-10-29 | 07:30 ET | [8-K](/filings/0001493152-24-042775.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-042775 |
| 2024-08-14 | 07:30 ET | [8-K](/filings/0001493152-24-031862.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-031862 |
| 2024-08-12 | 07:35 ET | [10-Q](/filings/0001493152-24-031150.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031150 |
| 2024-08-12 | 07:30 ET | [8-K](/filings/0001493152-24-031146.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031146 |
| 2024-07-09 | 16:30 ET | [8-K](/filings/0001493152-24-026640.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-026640 |
| 2024-05-15 | 07:35 ET | [10-Q](/filings/0001493152-24-019459.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019459 |
| 2024-05-15 | 07:30 ET | [8-K](/filings/0001493152-24-019449.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019449 |
| 2024-05-03 | 17:16 ET | [8-K](/filings/0001493152-24-017768.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017768 |
| 2024-05-03 | 06:45 ET | [8-K](/filings/0001493152-24-017625.md) | 2.02 Results of operations; 8.01 Other events | 0001493152-24-017625 |
| 2024-04-24 | 16:05 ET | [8-K](/filings/0001493152-24-015792.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-015792 |
| 2024-04-22 | 16:05 ET | [8-K](/filings/0001493152-24-015531.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-015531 |
| 2024-03-19 | 07:19 ET | [DEF 14A](/filings/0001493152-24-010421.md) | Proxy statement, period 2024-03-19 | 0001493152-24-010421 |
| 2024-03-18 | 08:36 ET | [8-K](/filings/0001493152-24-010206.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-010206 |
| 2024-03-18 | 07:35 ET | [10-K](/filings/0001493152-24-010190.md) | Annual report, period 2023-12-31 | 0001493152-24-010190 |

Page 1 of 7. [Older](/companies/abeo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:56 ET. No prices; not investment advice.